Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET
Company Participants
Susan Morrison - Executive Vice President and Chief Administrative Officer
John Sheridan - President and Chief Executive Officer
Brian Hansen - Executive Vice President and Chief Commercial Officer
Leigh Vosseller - Executive Vice President and Chief Financial Officer
Conference Call Participants
Matthew Miksic - Barclays
Steven Lichtman - Oppenheimer
Christopher Pasquale - Nephron Research
Brooks O'Neil - Lake Street Capital Markets
Nathan Treybeck - Wells Fargo Securities
Danielle Antalffy - UBS
Matthew Taylor - Jefferies
Matthew O'Brien - Piper Sandler
Jayson Bedford - Raymond James
Joanne Wuensch - Citi Research
Matthew Blackman - Stifel
Joshua Jennings - TD Cowen
Stephanie Piazzola - Bank of America Securities
Alexander Nowak - Craig-Hallum
Michael Polark - Wolfe Research
Operator
Good day and thank you for standing by. Welcome to Tandem Diabetes Care First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Susan Morrison, Executive Vice President, Chief Administrative Officer. Please go ahead.
Susan Morrison
Hello, everyone, and welcome to Tandem's First Quarter Earnings Call for 2023. We'd like to remind everyone that today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development timelines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.
A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or other factors.
Today's discussion will also include references to a number of GAAP and non-GAAP financial measures. Non-GAAP financial measures are provided to give our investors information that we believe is indicative of our core operating performance and reflects our ongoing business operations. We believe these non-GAAP financial measures facilitate better comparisons of operating results across reporting periods. Any non-GAAP information presented should not be considered as a substitution independently or superior to results prepared in accordance with GAAP. Please refer to our earnings release, quarterly report on Form 10-Q and the Investor Center portion of our website for a reconciliation of these measures to their most directly comparable GAAP financial measure.